Skip to content

Baseline power of theta oscillations predicts mystical-type experiences induced by DMT

Enzo Tagliazucchi, Federico Zamberlan, Federico Cavanna, Laura De la Fuente, Celeste Romero, Yonatan Sanz Perl, Carla Pallavicini

bioRxiv Preprint Server March 11, 2021 preprint DOI: 10.1101/2021.03.11.434994 via bioRxiv

Summary

Inhaled N,N-Dimethyltryptamine (DMT) was shown to alter neural oscillations, with frontal and temporal theta power inversely correlated with feelings of unity and transcendence during mystical-type experiences. The study suggests that reducing theta power before DMT administration may enhance the likelihood of such experiences, potentially improving therapeutic outcomes. These findings highlight the influence of a user's mental state on their psychedelic experience.

Study at a glance

Key finding Frontal and temporal theta oscillations were inversely correlated with feelings of unity and transcendence during DMT experiences.

Abstract

N,N-Dimethyltryptamine (DMT) is a classic psychedelic capable of inducing short-lasting but profound changes in consciousness. As with other psychedelics, the experience induced by DMT strongly depends upon contextual factors, yet the neurobiological determinants of this variability remain unknown. We combined wireless electroencephalography and source imaging to map changes in neural oscillations elicited by inhaled DMT. Furthermore, we found that the power of frontal and temporal theta oscillations was inversely correlated with scales indexing feelings of unity and transcendence, which are an integral part of the phenomenology of mystical-type experiences. Finally, we established the robustness of these results using a machine learning model for regression trained and tested following a cross-validation procedure. Our results are consistent with the observation that the state of mind prior to consuming a psychedelic drug influences the ensuing subjective experience of the user. We also suggest that priming subjects to reduce their theta power before administration of a serotonergic psychedelic could enhance the likelihood of inducing mystical-type experiences, leading to sustained positive effects in well-being and improving the outcome of therapeutic interventions.

Comments

No comments yet.

Log in to comment